Balchem Q3 sales down 5.9% to $229.9M, but EPS up to $0.90; record adjusted EBITDA $59.9M

BALCHEM CORP

2023-Q3 EPS reported $2.52 revenue$693,740,000

GAAP EPS $0.90 vs $0.78 prior year; adjusted EPS $1.04 vs $1.00.
Record quarterly adjusted EBITDA $59.9M, up 11.4% from $53.8M YoY.
Cash from ops $46.5M, free cash flow $38.2M; net debt reduced by $25M to $303.6M.
New board members: Olivier Rigaud (Corbion CEO) & Monica Vicente (Fresh Del Monte CFO) elected Sept 6.
Management: demand volatile, not yet normalized, but company well-positioned for recovery.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

BALCHEM CORP reported Q3 2023 results: revenue $229.9 million, net income $29.1 million, EPS $0.90.

Period: Q3 2023
Revenue: $229.9 million
Net income: $29.1 million
EPS: $0.90
Result: reported results

Exact text from the filing

Balchem Corporation (NASDAQ: BCPC) reported today third quarter net sales of $229.9 million for 2023, compared to net sales of $244.3 million in the prior year quarter. Third quarter net earnings were $29.1 million for 2023, compared to net earnings of $25.2 million for the third quarter 2022.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

BALCHEM CORP filing history →

Source: SEC EDGAR

accession 0001628280-23-035357

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.